- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
GlaxoSmithKline PLC
+ Add to WatchlistGSK:US
52.9700 USD 0.2400 0.46%As of 20:04:04 ET on 05/24/2013.
Company Profile for GlaxoSmithKline PLC (GSK)
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
Contact Information
GlaxoSmithKline PLC
980 Great West Road
Brentford, TW8 9GS
United Kingdom
Key Executives for GlaxoSmithKline PLC (GSK)
| Andrew WittyChief Executive Officer | Simon P DingemansChief Financial Officer |
| David RedfernChief Strategy Officer | Moncef SlaouiChairman:R&D & Vaccines |
| Roger ConnorPresident:Global Manufacturing | Deirdre P ConnellyPresident:North America |
| Shah Abbas HussainPresident:Europe & Emap | Patrick VallancePresident:Pharmaceuticals R&D |
| Emma WalmsleyPresident:Consumer Healthcare | Daniel E Troy "Dan"Senior VP/General Counsel |
| Simon Michael BicknellSenior VP:Governance & Ethics | Claire ThomasSenior VP:Human Resources |
| Bill LouvSenior VP:Core Bus Svcs | Philip Thomson "Phil"Senior VP:Global Communication |
| Victoria Anne WhyteSecretary | Marc DunoyerHead:Rare Diseases Unit |
| Sally FergusonInvestor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page